Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma, Nasopharyngeal”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Not Yet RecruitingNCT07373990
What this trial is testing

Short-course Tislelizumab Combined With Chemoradiotherapy for Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Cancinoma (NPC)Nasopharyngeal Cancer
Sun Yat-sen University 418
Early research (Phase 1)Study completedNCT03752398
What this trial is testing

XmAb®23104 in Subjects With Selected Advanced Solid Tumors (DUET-3)

Who this might be right for
Melanoma (Excluding Uveal Melanoma)Cervical CarcinomaPancreatic Carcinoma+13 more
Xencor, Inc. 198
Testing effectiveness (Phase 2)UnknownNCT02980315
What this trial is testing

A New EBV Related Technologies of T Cells in Treating Malignant Tumors and Clinical Application

Who this might be right for
Nasopharyngeal Neoplasms
The Second Hospital of Nanjing Medical University 20
Testing effectiveness (Phase 2)UnknownNCT04534855
What this trial is testing

A Phase II Clinical Study of Treprilimab in the Treatment of Recurrent Nasopharyngeal Carcinoma After Re-irradiation

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 40
Not applicableStudy completedNCT03810274
What this trial is testing

3DV+TPS Software Outlines the Radiotherapy of Nasopharyngeal Carcinoma

Who this might be right for
RadiotherapyNasopharyngeal Carcinoma
Xinqiao Hospital of Chongqing 300
Post-approval studies (Phase 4)UnknownNCT04292990
What this trial is testing

Comparison of Transdermal Fentanyl and Morphine for Oral Mucositis Pain in Nasopharyngeal Cancer Patients

Who this might be right for
PainNasopharyngeal CarcinomaHead and Neck Cancer+1 more
Jiarong Chen, MD 300
Large-scale testing (Phase 3)UnknownNCT02907710
What this trial is testing

Endostar Combined With Concurrent Chemoradiotherapy for Locoregionally Advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
First Affiliated Hospital of Guangxi Medical University 300
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07138989
What this trial is testing

EBV Lytic Reactivation Therapy Combined With PD-1 Antibody in Recurrent/Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Cancinoma (NPC)
Sun Yat-sen University 10
Large-scale testing (Phase 3)UnknownNCT02537925
What this trial is testing

The Effect of COX-2 Inhibitor on Radiosensitivity in Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Changjie Huang 120
Testing effectiveness (Phase 2)Study completedNCT00003850
What this trial is testing

Thalidomide in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
National Cancer Institute (NCI) 47
Testing effectiveness (Phase 2)UnknownNCT01347424
What this trial is testing

Evaluating Endostatin Plus TC Regimen in Secondary Malignant Neoplasm of Liver Using Contrast Enhancement Ultrasonography

Who this might be right for
Non Small Cell Lung CancerNasopharyngeal CancerLiver Metastasis
Sun Yat-sen University 40
Testing effectiveness (Phase 2)UnknownNCT03648697
What this trial is testing

EBV-TCR-T（YT-E001）for Patients With EBV-positive Recurrent or Metastatic NPC

Who this might be right for
Nasopharyngeal Carcinoma
Fujian Cancer Hospital 20
Not applicableActive Not RecruitingNCT06881225
What this trial is testing

Regulation of Blood-Brain Barrier Permeability by APOE Gene Polymorphism and Its Impact on Cognitive Function Post-Radiotherapy in Nasopharyngeal Carcinoma: An MRI Study

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 300
Testing effectiveness (Phase 2)Looking for participantsNCT07038343
What this trial is testing

AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)

Who this might be right for
Solid Tumor CancerLocally AdvancedMetastatic Solid Tumors+5 more
Avenzo Therapeutics, Inc. 480
Not applicableStudy completedNCT07741110
What this trial is testing

Biomarker Analysis Data From a Randomized Phase II Study in Patients With Nasopharyngeal Carcinoma Treated With Chemotherapy and Radiotherapy

Who this might be right for
Nasopharyngeal Carcinoma (NPC)
Hellenic Cooperative Oncology Group 141
Large-scale testing (Phase 3)Not Yet RecruitingNCT04215510
What this trial is testing

Early Recurrent Nasopharyngeal Cancer: the Effect of Surgery vs IMRT

Who this might be right for
Recurrent Nasopharyngeal Carcinoma
Eye & ENT Hospital of Fudan University 286
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07320963
What this trial is testing

Chidamide in Combination With Toripalimab and Anlotinib in Recurrent/Metastatic Nasopharyngeal Carcinoma.

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 52
Not applicableEnded earlyNCT03049358
What this trial is testing

Olfactory Training in Improving Sense of Smell After Radiation Therapy in Patients With Paranasal Sinus or Nasopharyngeal Cancer

Who this might be right for
Stage 0 Nasopharyngeal CarcinomaStage 0 Paranasal Sinus CancerStage I Nasopharyngeal Carcinoma+15 more
Stanford University 15
Testing effectiveness (Phase 2)Study completedNCT01392235
What this trial is testing

Famitinib in Treating Patients With Recurrent and/or Metastatic Nasopharyngeal Carcinoma (NPC)

Who this might be right for
Recurrent Nasopharyngeal CarcinomaMetastatic Nasopharyngeal Carcinoma
Jiangsu HengRui Medicine Co., Ltd. 58
Testing effectiveness (Phase 2)UnknownNCT02421640
What this trial is testing

Phase II Trial of TIL Following CCRT in Patients With Locoregionally Advanced NPC

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 116
Next Page